ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 140 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $50,000 | +8.7% | 10,600 | 0.0% | 0.00% | – |
| Q3 2019 | $46,000 | -94.9% | 10,600 | -93.2% | 0.00% | -100.0% |
| Q2 2019 | $906,000 | -54.0% | 155,400 | -69.6% | 0.00% | -83.3% |
| Q1 2019 | $1,970,000 | +139.7% | 511,600 | +16.4% | 0.01% | +100.0% |
| Q4 2018 | $822,000 | -23.6% | 439,600 | +159.2% | 0.01% | 0.0% |
| Q1 2017 | $1,076,000 | +75.8% | 169,600 | +48.3% | 0.01% | +50.0% |
| Q4 2016 | $612,000 | -5.0% | 114,400 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $644,000 | – | 114,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 17,815,708 | $47,033,000 | 2.93% |
| Essex Woodlands Management, Inc. | 2,764,908 | $7,130,000 | 2.60% |
| Belmont Global Advisors, Inc. | 973,000 | $2,569,000 | 2.01% |
| Belmont Global Advisors, Inc. | 135,700 | $358,000 | 0.28% |
| MSD Partners, L.P. | 2,750,000 | $7,260,000 | 0.22% |
| SFMG, LLC | 99,850 | $264,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,090 | $29,000 | 0.03% |
| WESTPORT RESOURCES MANAGEMENT INC | 33,500 | $88,000 | 0.02% |
| SMITH ASSET MANAGEMENT GROUP LP | 236,590 | $625,000 | 0.02% |
| GM Advisory Group, LLC | 10,500 | $28,000 | 0.02% |